This inventor holds 1 USPTO granted patent. Top assignee: National Taiwan University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Hao-Wei Han: Innovator in Angiogenic Co-Spheroids
Introduction
Hao-Wei Han is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biomedical engineering, particularly in the development of methods for preparing mimicking angiogenic co-spheroids. His innovative work has the potential to advance research in angiogenesis and tissue engineering.
Latest Patents
Hao-Wei Han holds a patent titled "Method of preparing mimicking angiogenic co-spheroids and application thereof." This patent describes a method that involves co-culturing a neural-related cell and a cultured cell on hyaluronan-grafted chitosan (CS-HA) substrates to form a co-spheroid. The co-spheroid is then encapsulated into a hydrogel to create a mimicking angiogenic co-spheroid. This technology can be utilized in a high-throughput angiogenesis screening platform, showcasing its applicability in advanced biomedical research.
Career Highlights
Hao-Wei Han is affiliated with National Taiwan University, where he continues to engage in cutting-edge research. His work focuses on the intersection of materials science and biology, aiming to create innovative solutions for complex biological challenges.
Collaborations
Hao-Wei Han collaborates with fellow researcher Shan-hui Hsu, contributing to the advancement of their shared research interests. Their partnership enhances the potential for groundbreaking discoveries in their field.
Conclusion
Hao-Wei Han's contributions to the field of biomedical engineering, particularly through his patent on mimicking angiogenic co-spheroids, highlight his role as an innovator. His work at National Taiwan University and collaborations with other researchers position him as a key figure in advancing tissue engineering and angiogenesis research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
